Common Effects Ozempic may cause nausea, vomiting, diarrhea, constipation, decreased appetite, mild abdominal pain, injection-site reactions, and occasional dizziness
Poorly reconstituted solutions form depots that artificially extend apparent half-life through delayed release rather than prolonged circulation
Staying well hydrated helps
For the current regulatory landscape affecting all peptides, see FDA peptide crackdown 2026
Jayne Hornung, chief clinical officer at Managed Markets Insight and Technology, suggests initial pricing of oral GLP-1s for weight loss could be reminiscent of the early days of anti-CGRP medications for migraines when the first oral CGRP came to market in 2019, the pricing still remained high
Tirzepatide represents the optimal choice for patients seeking maximum weight loss efficacy who can tolerate gastrointestinal side effects and afford higher treatment costs